Evidence map›Paper›PMID 33802821›Full record

ReviewPolymers2021

CeO

Alexander B Shcherbakov, Vladimir V Reukov, Alexander V Yakimansky, Elena L Krasnopeeva, Olga S Ivanova, Anton L Popov, Vladimir K Ivanov

Open access · goldAbstract readReview
In one paragraph

Review in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 170 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Alexander B ShcherbakovZabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 03680 Kyiv, Ukraine.ORCID 0000-0002-0020-0913
Vladimir V ReukovDepartment of Textiles, Merchandising and Interiors, University of Georgia, Athens, GA, 30602, USA.ORCID 0000-0003-1695-6712
Alexander V YakimanskyInstitute of Macromolecular Compounds, Russian Academy of Sciences, 199004 St. Petersburg, Russia.
Elena L KrasnopeevaInstitute of Macromolecular Compounds, Russian Academy of Sciences, 199004 St. Petersburg, Russia.
Olga S IvanovaKurnakov Institute of General and Inorganic Chemistry of the Russian Academy of Sciences, 119991 Moscow, Russia.
Anton L PopovKurnakov Institute of General and Inorganic Chemistry of the Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-2643-4846
Vladimir K IvanovKurnakov Institute of General and Inorganic Chemistry of the Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-2343-2140
Institute of Macromolecular Compounds · RUNS Kurnakova Institute of General and Inorganic Chemistry · RUDanylo Zabolotny Institute of Microbiology and Virology · UAInstitute of Theoretical and Experimental Biophysics · RUUniversity of Georgia · US

Funding

Russian Science Foundation 19-13-00416
6 · The paper itself

Abstract

The development of advanced composite biomaterials combining the versatility and biodegradability of polymers and the unique characteristics of metal oxide nanoparticles unveils new horizons in emerging biomedical applications, including tissue regeneration, drug delivery and gene therapy, theranostics and medical imaging. Nanocrystalline cerium(IV) oxide, or nanoceria, stands out from a crowd of other metal oxides as being a truly unique material, showing great potential in biomedicine due to its low systemic toxicity and numerous beneficial effects on living systems. The combination of nanoceria with new generations of biomedical polymers, such as PolyHEMA (poly(2-hydroxyethyl methacrylate)-based hydrogels, electrospun nanofibrous polycaprolactone or natural-based chitosan or cellulose, helps to expand the prospective area of applications by facilitating their bioavailability and averting potential negative effects. This review describes recent advances in biomedical polymeric material practices, highlights up-to-the-minute cerium oxide nanoparticle applications, as well as polymer-nanoceria composites, and aims to address the question: how can nanoceria enhance the biomedical potential of modern polymeric materials?

Indexed as

biocompositesCOVID-19hybrid materialsnanomaterialstherapy

Identifiers

PMID33802821
PMCPMC8002506
OpenAlexW3137131371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.